Manhattan Scientifics, Inc. Reports Earnings Results for the Second Quarter Ended June 30, 2021
August 23, 2021 at 02:25 pm
Share
Manhattan Scientifics, Inc. announced earnings results for the second quarter ended June 30, 2021. For the second quarter, the company announced sales was USD 50,000 compared to USD 50,000 a year ago. Operating loss was USD 161,000 compared to USD 128,000 a year ago. Net loss was USD 2.583 million compared to net income of USD 528,000 a year ago. For the half year, sales was USD 50,000 compared to USD 50,000 a year ago. Operating loss was USD 345,000 compared to USD 300,000 a year ago. Net loss was USD 2.449 million compared to USD 204,000 a year ago.
Manhattan Scientifics, Inc. is focused on technology transfer and commercialization of these transformative technologies. The Company operates as a technology incubator. Its business model is to identify significant technologies; acquire them or the rights to them; secure the services of inventors, engineers or other staff who were instrumental in their creation; provide or contract for suitable work facilities, laboratories, and other aids where appropriate; prototype the technologies to demonstrate proof of principle feasibility; secure patent and or other intellectual property protection; secure early customers for product trials where feasible and appropriate; and commercialize through licenses, sales or cooperative efforts with other manufacturing and distribution firms. Its business model is based on licensing metals technology to metals manufacturers. Its technologies are in a development phase.
MANHATTAN SCIENTIFICS, INC. 
